Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrating network pharmacology and Mendelian randomization to explore potential targets of Fufang Banmao capsule against non-small cell lung cancer.

Pakistan journal of pharmaceutical sciences - 1 Apr 2026

Wei Zhicheng, Hu Yunyun, Zuo Fang, Liu Conghai, Wu Desheng, Sun Xiaodong

Abstract excerpt

BACKGROUND: Fufang Banmao Capsule (FBC) is clinically applied in the treatment of non-small cell lung cancer (NSCLC), yet its underlying pharmacological mechanism remains to be fully elucidated. OBJECTIVES: This study aimed to systematically elucidate the pharmacological actions of FBC against NSCLC by integrating network pharmacology and Mendelian randomization approaches. METHODS: Active components and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Phytogenic
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drugs, Chinese Herbal

Share to Lung Neoplasms

Share to Mendelian Randomization Analysis

Share to Molecular Docking Simulation

Share to Polymorphism, Single Nucleotide

Share to Protein Interaction Maps

Source

Identifiers

PMID: 41761800
DOI: 10.36721/PJPS.2026.39.4.REG.13644.1

Genes

PIK3CA
TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrating network pharmacology and Mendelian randomization to explore potential targets of Fufang Banmao capsule against non-small cell lung cancer.PMID 41761800Read ↗

Combining network pharmacology and transcriptomics to validate and explore the efficacy and mechanism of Huayu Wan in treating non-small cell lung cancerSemantic proximity Read ↗

Unveiling novel potential drug targets for lung cancer through Mendelian randomization analysis.Semantic proximity Read ↗

Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro ValidationSemantic proximity Read ↗

Systematic Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinomaSemantic proximity Read ↗

Uncovering the Mechanism of Shenlian Capsules in the Treatment of Non-small Cell Lung Cancer by System PharmacologySemantic proximity Read ↗

Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancerSemantic proximity Read ↗

A Network Pharmacology Approach to Explore the Potential Mechanisms of Huangqin-Baishao Herb Pair in Treatment of CancerSemantic proximity Read ↗

Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analysesSemantic proximity Read ↗

Exploring the mechanisms of Shenmai injection against Chronic Obstructive Pulmonary Disease based on network pharmacology and molecular docking validationSemantic proximity Read ↗

Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacologySemantic proximity Read ↗

Potential drug targets for tumors identified through Mendelian randomization analysis.Semantic proximity Read ↗

Molecular targets and mechanisms of cortex mori for lung cancer treatment: A network pharmacology study, molecular docking and experimental validationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.